Work

Prevalence of Pulmonary Arterial Hypertension Associated with Congenital Heart Disease Following Defect Correction: A Systematic Review and Meta-analysis

Year: 2026
Type: article
Abstract: Importance Understanding the disease burden of repaired pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD) is essential for guiding healthcare strategies, yet data are lacking in this area. Objective To estimate the prevalence of pulmonary arterial hypertension (PAH) following defect correction in patients with congenital heart disease (CHD). Data sources A systematic review and meta-analysis was performed using PubMed, Embase and Cochrane databases. Study selection Longitudinal cohort published between 1970-2023 involving CHD patients who underwent defect correction and were subsequently diagnosed with PAH were reviewed. Eligible studies reporting the prevalence of repaired PAH-CHD at least 3 months post-repair was included. Study selection was conducted independently by two reviewers. The primary outcome was the prevalence of PAH in patients following CHD defect correction. Results Across 58 studies (7,036 participants), the random-effects pooled prevalence of reported post-repair PAH/PH was 10.8% (95% CI 7.3-15.0, I2 = 95.6%; prediction interval 0-50.1%). Prevalence was 9.0% (95% CI 3.3-17) in studies using right heart catheterisation, 19.3% (CI 10.6-29.7) in studies using echocardiography and 16.1% (CI 8.6- 25.1%) in studies using both modalities (p=0.19). Prevalence was highest in the adult-only cohort (18.5%, 95%CI 11.8-26.2) and lower in paediatric only (7.6%, 95%CI 3-13.5) and mixed-age cohorts (7.5%,95%CI1.7-16.3), p=0.039. Preoperative pulmonary hypertension (PH) was the strongest predictor of post-repair PAH and remained predictive on adjusted meta-regression (p<0.01). Conclusion and relevance PAH following defect repair remains a significant clinical dilemma requiring standardised diagnostic criteria and robust risk stratification tools to guide management.
Language: English
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $4,591
OpenAlex ID: W7224231358
FWCI:
Cites:
Cited by:
Related to: 10